Skip to main content
Retour
Watch Compare

ENvue Medical, Inc.

Qualité des données : 100%
FEED
Nasdaq Manufacturing Measuring & Analyzing Instruments
1,75 €
▼ 0,09 € (-4,89%)
Cap. Boursière: 1,90 M
Prix
1,75 €
Cap. Boursière
1,90 M
Fourchette du Jour
1,68 € — 1,81 €
Fourchette 52 Semaines
0,99 € — 88,20 €
Volume
133 428
Ouverture 1,80 €
Moyenne 50J / 200J
2,22 €
21,26% below
Moyenne 50J / 200J
4,98 €
64,87% below

Quick Summary

Points Clés

Revenue grew 42,35% annually over 5 years — strong growth
Negative free cash flow of -7,28 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 30,30%
Capital efficient — spends only 1,38% of revenue on capex

Croissance

Revenue Growth (5Y)
42,35%
Au-dessus de la moyenne du secteur (1,82%)
Revenue (1Y)12,05%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-16,31%
Au-dessus de la moyenne du secteur (-53,41%)
ROIC-17,02%
Net Margin-251,92%
Op. Margin-351,77%

Sécurité

Debt / Equity
N/A
Current Ratio0,86
Interest Coverage-33,26

Valorisation

PE (TTM)
-0,28
Au-dessus de la moyenne du secteur (-1,48)
P/B Ratio0,04
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -0,3 -1,5
P/B 0,0 1,6
ROE % -16,3 -53,4
Net Margin % -251,9 -41,5
Rev Growth 5Y % 42,4 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 12,05% Revenue Growth (3Y) 84,43%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 42,35% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 2,69 M Net Income (TTM) -6,76 M
ROE -16,31% ROA -12,78%
Gross Margin 30,02% Operating Margin -351,77%
Net Margin -251,92% Free Cash Flow (TTM) -7,28 M
ROIC -17,02% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,86
Interest Coverage -33,26 Asset Turnover 0,05
Working Capital -1,63 M Tangible Book Value -1,44 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,28 Forward P/E N/A
P/B Ratio 0,04 P/S Ratio 0,71
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -382,34%
Market Cap 1,90 M Enterprise Value -5,05 M
Per Share
EPS (Diluted TTM) -19,58 Revenue / Share 2,47
FCF / Share -6,69 OCF / Share -6,66
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 1,38% FCF Conversion 107,64%
SBC-Adj. FCF -7,50 M Growth Momentum -30,30

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 2,56 M 2,28 M 752 000,0 1,70 M 623 000,0
Net Income -3,71 M -3,71 M -5,45 M -14,28 M -4,33 M
EPS (Diluted) -13,73 -2,12 — — —
Gross Profit 1,51 M 1,54 M 167 000,0 770 000,0 214 000,0
Operating Income -3,58 M -3,44 M -5,01 M -5,68 M -4,72 M
EBITDA — — — — —
R&D Expenses 909 000,0 185 000,0 283 000,0 293 000,0 171 000,0
SG&A Expenses — — — — —
D&A 1 000,0 1 000,0 1 000,0 2 000,0 2 000,0
Interest Expense 135 000,0 135 000,0 347 000,0 147 000,0 147 000,0
Income Tax 19 000,0 29 000,0 35 000,0 32 000,0 15 000,0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 3,63 M 6,67 M 5,88 M 8,62 M 8,23 M
Total Liabilities 3,00 M 2,69 M 2,65 M 2,31 M 5,84 M
Shareholders' Equity 627 000,0 3,99 M 3,23 M 6,31 M 2,39 M
Total Debt — — — — —
Cash & Equivalents — — — 7,74 M 7,14 M
Current Assets 3,33 M 6,49 M 5,61 M 8,34 M 7,97 M
Current Liabilities 2,72 M 2,45 M 2,32 M 1,90 M 2,90 M